Publications

Detailed Information

High Serum Bilirubin Is Associated with the Reduced Risk of Diabetes Mellitus and Diabetic Nephropathy

DC Field Value Language
dc.contributor.authorHan, Seung Seok-
dc.contributor.authorNa, Ki Young-
dc.contributor.authorChae, Dong-Wan-
dc.contributor.authorKim, Yon Su-
dc.contributor.authorChin, Ho Jun-
dc.contributor.authorKim, Suhnggwon-
dc.date.accessioned2012-05-29T04:12:28Z-
dc.date.available2012-05-29T04:12:28Z-
dc.date.issued2010-06-
dc.identifier.citationTOHOKU JOURNAL OF EXPERIMENTAL MEDICINE; Vol.221 2; 133-140ko_KR
dc.identifier.issn0040-8727-
dc.identifier.urihttps://hdl.handle.net/10371/76527-
dc.description.abstractSeveral studies have suggested a potential effect of serum bilirubin as an antioxidant and cytoprotectant factor. For the results presented here, we evaluated the correlation between serum bilirubin and diabetes mellitus (DM) or chronic kidney disease originated from DM (DMCKD) in a Korean population. We used a cross-sectional, population-based design to examine 93,909 subjects (aged 18-96 years, 53.0% male). The trend of P values in the odds ratios for being DM and DMCKD was calculated using patients separated into five groups based on individual serum bilirubin concentrations. The prevalence of DM and DMCKD was 6.7% and 0.8%, respectively. Higher serum bilirubin levels were significantly associated with decreased prevalence of DM in both men (P trend < 0.001) and women (P trend = 0.014). The risk of DMCKD also decreased as bilirubin levels increased in women (P trend = 0.011), but not in men (P trend = 0.467). Serum bilirubin level was inversely related to insulin resistance using the homeostasis model assessment (HOMA-IR), serum insulin, and C-reactive protein (CRP) levels in multiple linear regression analyses. The regression coefficients (B) of log-HOMA-IR, log-insulin, and log-CRP were as follows: -0.09, -0.13, and -0.60 in men; -0.07, -0.09, and -0.50 in women, respectively. All the regressions were statistically significant (P < 0.001). These results indicate that serum bilirubin might have some protective function against DM and DMCKD, although the association between high serum bilirubin and decreased prevalence of DMCKD is observed only in women.ko_KR
dc.language.isoenko_KR
dc.publisherTOHOKU UNIV MEDICAL PRESSko_KR
dc.subjectbilirubinko_KR
dc.subjectmetabolic syndromeko_KR
dc.subjectdiabetic nephropathyko_KR
dc.subjectchronic kidney diseaseko_KR
dc.subjectdiabetes mellitusko_KR
dc.titleHigh Serum Bilirubin Is Associated with the Reduced Risk of Diabetes Mellitus and Diabetic Nephropathyko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor한승석-
dc.contributor.AlternativeAuthor나기영-
dc.contributor.AlternativeAuthor채동완-
dc.contributor.AlternativeAuthor김연수-
dc.contributor.AlternativeAuthor김성권-
dc.contributor.AlternativeAuthor진호준-
dc.identifier.doi10.1620/tjem.221.133-
dc.citation.journaltitleTOHOKU JOURNAL OF EXPERIMENTAL MEDICINE-
dc.description.citedreferenceLee SC, 2009, KIDNEY INT, V76, P838, DOI 10.1038/ki.2009.286-
dc.description.citedreferenceSong FF, 2009, AM J EPIDEMIOL, V170, P747, DOI 10.1093/aje/kwp196-
dc.description.citedreferenceLin JP, 2009, ATHEROSCLEROSIS, V206, P228, DOI 10.1016/j.atherosclerosis.2009.02.039-
dc.description.citedreferenceJohnson AD, 2009, HUM MOL GENET, V18, P2700, DOI 10.1093/hmg/ddp202-
dc.description.citedreferenceChin HJ, 2009, J KOREAN MED SCI, V24, pS22, DOI 10.3346/jkms.2009.24.S1.S22-
dc.description.citedreferenceFukui M, 2008, KIDNEY INT, V74, P1197, DOI 10.1038/ki.2008.398-
dc.description.citedreferenceIdriss NK, 2008, J AM COLL CARDIOL, V52, P971, DOI 10.1016/j.jacc.2008.06.019-
dc.description.citedreferenceChen YH, 2008, DIABETES CARE, V31, P1615, DOI 10.2337/dc07-2126-
dc.description.citedreferenceMuoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327-
dc.description.citedreferencePerlstein TS, 2008, ARTERIOSCL THROM VAS, V28, P166, DOI 10.1161/ATVBAHA.107.153262-
dc.description.citedreferencePACHORI AS, 2007, J MOL CELL CARDIOL, V43, P580-
dc.description.citedreferenceCowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062-
dc.description.citedreferenceGoodman AI, 2006, J AM SOC NEPHROL, V17, P1073, DOI 10.1681/ASN.2004121082-
dc.description.citedreferenceOllinger R, 2005, CIRCULATION, V112, P1030, DOI 10.1161/CIRCULATIONAHA.104.528802-
dc.description.citedreferenceLerner-Marmarosh N, 2005, P NATL ACAD SCI USA, V102, P7109, DOI 10.1073/pnas.0502173102-
dc.description.citedreferenceToth B, 2003, ARCH SURG-CHICAGO, V138, P1375-
dc.description.citedreferenceAbraham NG, 2003, CIRC RES, V93, P507, DOI 10.1161/01.RES.0000091828.36599.34-
dc.description.citedreferenceCook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821-
dc.description.citedreferenceMaritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058-
dc.description.citedreferenceBaranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999-
dc.description.citedreferenceHostetter TH, 2001, NEW ENGL J MED, V345, P910-
dc.description.citedreferenceLevey AS, 1999, ANN INTERN MED, V130, P461-
dc.description.citedreferenceDore S, 1999, P NATL ACAD SCI USA, V96, P2445-
dc.description.citedreferenceHaffner SM, 1997, DIABETES CARE, V20, P1087-
dc.description.citedreferenceLIN LY, 1996, ATHEROSCLEROSIS, V203, P563-
dc.description.citedreferenceSTOCKER R, 1987, SCIENCE, V235, P1043-
dc.description.citedreferenceROSENTHAL P, 1984, CLIN CHEM, V30, P1380-
dc.description.citedreferenceMURACA M, 1983, CLIN SCI, V64, P85-
dc.description.citedreferenceARIAS IM, 1966, MEDICINE, V45, P513-
dc.description.citedreferenceBERNHARD K, 1954, HELV CHIM ACTA, V37, P306-
dc.description.tc5-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share